Prospective phase II trial of pre-resection thoracoscopic (VATS) restaging following neoadjuvant therapy for IIIA(N2) non-small cell lung cancer (NSCLC): Results of CALGB 39803.
Publication
, Conference
Jaklitsch, MT; Gu, L; Harpole, DH; D'Amico, TA; McKenna, RJ; Krasna, MJ; Kohman, LJ; Swanson, SJ; Decamp, MM; Sugarbaker, DJ
Published in: JOURNAL OF CLINICAL ONCOLOGY
June 1, 2005
Duke Scholars
Published In
JOURNAL OF CLINICAL ONCOLOGY
EISSN
1527-7755
ISSN
0732-183X
Publication Date
June 1, 2005
Volume
23
Issue
16
Start / End Page
636S / 636S
Location
Orlando, FL
Publisher
AMER SOC CLINICAL ONCOLOGY
Conference Name
41st Annual Meeting of the American-Society-of-Clinical-Oncology
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Jaklitsch, M. T., Gu, L., Harpole, D. H., D’Amico, T. A., McKenna, R. J., Krasna, M. J., … Sugarbaker, D. J. (2005). Prospective phase II trial of pre-resection thoracoscopic (VATS) restaging following neoadjuvant therapy for IIIA(N2) non-small cell lung cancer (NSCLC): Results of CALGB 39803. In JOURNAL OF CLINICAL ONCOLOGY (Vol. 23, pp. 636S-636S). Orlando, FL: AMER SOC CLINICAL ONCOLOGY.
Jaklitsch, M. T., L. Gu, D. H. Harpole, T. A. D’Amico, R. J. McKenna, M. J. Krasna, L. J. Kohman, S. J. Swanson, M. M. Decamp, and D. J. Sugarbaker. “Prospective phase II trial of pre-resection thoracoscopic (VATS) restaging following neoadjuvant therapy for IIIA(N2) non-small cell lung cancer (NSCLC): Results of CALGB 39803.” In JOURNAL OF CLINICAL ONCOLOGY, 23:636S-636S. AMER SOC CLINICAL ONCOLOGY, 2005.
Jaklitsch MT, Gu L, Harpole DH, D’Amico TA, McKenna RJ, Krasna MJ, et al. Prospective phase II trial of pre-resection thoracoscopic (VATS) restaging following neoadjuvant therapy for IIIA(N2) non-small cell lung cancer (NSCLC): Results of CALGB 39803. In: JOURNAL OF CLINICAL ONCOLOGY. AMER SOC CLINICAL ONCOLOGY; 2005. p. 636S-636S.
Jaklitsch, M. T., et al. “Prospective phase II trial of pre-resection thoracoscopic (VATS) restaging following neoadjuvant therapy for IIIA(N2) non-small cell lung cancer (NSCLC): Results of CALGB 39803.” JOURNAL OF CLINICAL ONCOLOGY, vol. 23, no. 16, AMER SOC CLINICAL ONCOLOGY, 2005, pp. 636S-636S.
Jaklitsch MT, Gu L, Harpole DH, D’Amico TA, McKenna RJ, Krasna MJ, Kohman LJ, Swanson SJ, Decamp MM, Sugarbaker DJ. Prospective phase II trial of pre-resection thoracoscopic (VATS) restaging following neoadjuvant therapy for IIIA(N2) non-small cell lung cancer (NSCLC): Results of CALGB 39803. JOURNAL OF CLINICAL ONCOLOGY. AMER SOC CLINICAL ONCOLOGY; 2005. p. 636S-636S.
Published In
JOURNAL OF CLINICAL ONCOLOGY
EISSN
1527-7755
ISSN
0732-183X
Publication Date
June 1, 2005
Volume
23
Issue
16
Start / End Page
636S / 636S
Location
Orlando, FL
Publisher
AMER SOC CLINICAL ONCOLOGY
Conference Name
41st Annual Meeting of the American-Society-of-Clinical-Oncology
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences